This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Burton A. Waisbren, Sr, MD
Milwaukee, Wis

JAMA. 1997;277(14):1124.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor.

—I read with interest and appreciation the recent Landmark Perspective and the discussion regarding the hepatitis B vaccine by Dr Douglas.¹ However, I find it somewhat disturbing that Douglas did not mention the potential untoward results of viral vaccines, or those already reported as presumably being due to the hepatitis B vaccine.

Douglas must be aware of the untoward results from the vaccine, not only because of lawsuits his company has settled in which demyelinating disease was involved, but also because of reports of adverse reactions linked to vaccine use in the medical literature,^2-4 including multiple sclerosis—like diseases, Guillain-Barré syndrome, optic neuritis, and transverse myelitis.

Despite these reports, the strategy of universal vaccination in the United States has been promoted widely by Merck, the Centers for Disease Control and Prevention, and others.^5,6 Should not the parents of infants be made aware of the potential . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?